Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Metabolism of [14C] BMS-986142 in Healthy Males
NCT02880670Phase 1Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of BMS-986142 in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Primary endpoints: Pharmacokinetic parameters and Total radioactivity recovery. Started Aug 2016; status: completed.
02
Drugs
BMS-986142
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02880670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02880670.